Predict your next investment

Kallyope company logo
HEALTHCARE | Biotechnology
kallyope.com

See what CB Insights has to offer

Total Raised

$243M

Investors Count

11

Deal Terms

2

Kallyope Funding, Kallyope Valuation & Kallyope Revenue

4 Fundings

Kallyope's latest funding round was a Series C for $112M on March 25, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/25/2020

Series C

$112M

$0.00B

((9.99x))

FY 1234

9

12/5/2018

Series B - II

$99M

$0.00B

((9.99x))

FY 1234

10

2/22/2018

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

10/16/2015

Series A

$99M

$0.00B

((9.99x))

FY 1234

10

Date

3/25/2020

12/5/2018

2/22/2018

10/16/2015

Round

Series C

Series B - II

Series B

Series A

Amount

$112M

$99M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

9

10

10

10

Kallyope Deal Terms

2 Deal Terms

Kallyope's deal structure is available for 2 funding rounds, including their Series B from February 22, 2018.

Round

Series B

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

$99M

Dividend Rate

$99M

Liquidation Preferences

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series A

Kallyope Investors

11 Investors

Kallyope has 11 investors. Lux Capital invested in Kallyope's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/16/2015

3/25/2020

4
Series A, Series B (2018), Series B - II (2018), Series C (2020)

Venture Capital

New York

10/16/2015

3/25/2020

4
Series A, Series B (2018), Series B - II (2018), Series C (2020)

Venture Capital

California

10/16/2015

3/25/2020

4
Series A, Series B (2018), Series B - II (2018), Series C (2020)

Venture Capital

Massachusetts

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Corporate Venture

California

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

New York

First funding

10/16/2015

10/16/2015

10/16/2015

00/00/0000

00/00/0000

Last Funding

3/25/2020

3/25/2020

3/25/2020

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

4
Series A, Series B (2018), Series B - II (2018), Series C (2020)
4
Series A, Series B (2018), Series B - II (2018), Series C (2020)
4
Series A, Series B (2018), Series B - II (2018), Series C (2020)

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Type

Venture Capital

Venture Capital

Venture Capital

Corporate Venture

Venture Capital

Location

New York

California

Massachusetts

California

New York

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.